Literature DB >> 19340344

Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity.

Suree Lekawanvijit1, Nipon Chattipakorn.   

Abstract

Patients with thalassemia major have inevitably suffered from complications of the disease, due to iron overload. Among such complications, cardiomyopathy is the leading cause of morbidity and mortality (63.6% to 71%). The major causes of death in this group of patients are congestive heart failure and fatal cardiac tachyarrhythmias leading to sudden cardiac death. The free radical-mediated pathway is the principal mechanism of iron toxicity. The consequent series of events caused by iron overload lead to catastrophic cardiac effects. The authors review the electrophysiological and molecular mechanisms, pathophysiology and correlated clinical insight of heart failure and arrhythmias in iron overload thalassemic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340344      PMCID: PMC2706758          DOI: 10.1016/s0828-282x(09)70064-9

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  85 in total

1.  LATE CARDIAC COMPLICATIONS OF CHRONIC, SEVERE, REFRACTORY ANEMIA WITH HEMOCHROMATOSIS.

Authors:  M A ENGLE; M ERLANDSON; C H SMITH
Journal:  Circulation       Date:  1964-11       Impact factor: 29.690

2.  Baroreflex function in conscious rats submitted to iron overload.

Authors:  L M Cardoso; M L Pedrosa; M E Silva; M F D Moraes; E Colombari; D A Chianca
Journal:  Braz J Med Biol Res       Date:  2005-02-15       Impact factor: 2.590

3.  Re-evaluation of cytotoxicity and iron chelation activity of three beta-diketones by semiempirical molecular orbital method.

Authors:  Mariko Ishihara; Hiroshi Sakagami
Journal:  In Vivo       Date:  2005 Jan-Feb       Impact factor: 2.155

4.  Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease.

Authors:  Y A Kuryshev; G M Brittenham; H Fujioka; P Kannan; C C Shieh; S A Cohen; A M Brown
Journal:  Circulation       Date:  1999-08-10       Impact factor: 29.690

5.  Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia.

Authors:  C De Luca; A Filosa; M Grandinetti; F Maggio; M Lamba; S Passi
Journal:  Free Radic Res       Date:  1999-06

Review 6.  Thalassemia.

Authors:  Alan R Cohen; Renzo Galanello; Dudley J Pennell; Melody J Cunningham; Elliott Vichinsky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

7.  Antioxidant and antiproliferative activity of curcumin semicarbazone.

Authors:  Sabari Dutta; Subhash Padhye; K Indira Priyadarsini; Chris Newton
Journal:  Bioorg Med Chem Lett       Date:  2005-06-02       Impact factor: 2.823

8.  Early detection of cardiac dysfunction in thalassemic patients by radionuclide angiography and heart rate variability analysis.

Authors:  Benedetta De Chiara; Wilma Crivellaro; Roberto Sara; Livia Ruffini; Marina Parolini; Vlasta Fesslovà; Vittorio Carnelli; Cesare Fiorentini; Oberdan Parodi
Journal:  Eur J Haematol       Date:  2005-06       Impact factor: 2.997

Review 9.  Iron metabolism and toxicity.

Authors:  G Papanikolaou; K Pantopoulos
Journal:  Toxicol Appl Pharmacol       Date:  2005-01-15       Impact factor: 4.219

10.  Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.

Authors:  M T Rizzo; E Regazzi; D Garau; L Akard; M Dugan; H S Boswell; V Rizzoli; C Carlo-Stella
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  39 in total

1.  Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients.

Authors:  Man Wang; Rongrong Liu; Yuzhen Liang; Gaohui Yang; Yumei Huang; Chunlan Yu; Kaiqi Sun; Yongrong Lai; Yang Xia
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

2.  Determining Nt-proBNP Levels with Diastolic Dysfunction in Thalassemia Major Patients.

Authors:  Mable Misha Singh; Ravindra Kumar; Satyendra Tewari; Sarita Agarwal
Journal:  J Pediatr Genet       Date:  2017-05-11

Review 3.  Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients.

Authors:  Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Gerardo Nigro
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-06-20       Impact factor: 1.468

4.  Astragalus polysaccharides meliorate cardiovascular dysfunction in iron-overloaded thalassemic mice.

Authors:  Xue Yang; Xiaoxi Zhu; Xianying Tang; Mei Liu; Huiling Zheng; Lin Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-12

5.  Early detection of ventricular dysfunction by tissue Doppler echocardiography related to cardiac iron overload in patients with thalassemia.

Authors:  Suchaya Silvilairat; Pimlak Charoenkwan; Suwit Saekho; Adisak Tantiworawit; Somdet Srichairatanakool
Journal:  Int J Cardiovasc Imaging       Date:  2020-07-29       Impact factor: 2.357

6.  Neurobehavioural Toxicity of Iron Oxide Nanoparticles in Mice.

Authors:  Vasanth Dhakshinamoorthy; Vijayprakash Manickam; Ekambaram Perumal
Journal:  Neurotox Res       Date:  2017-03-20       Impact factor: 3.911

Review 7.  Cardiac complications in beta-thalassemia: From mice to men.

Authors:  Sirinart Kumfu; Suthat Fucharoen; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-09

8.  A chemical screen identifies small molecules that regulate hepcidin expression.

Authors:  Vera Gaun; Bonnie Patchen; Josephine Volovetz; Aileen W Zhen; Aleksandr Andreev; Michael P Pollastri; Paula G Fraenkel
Journal:  Blood Cells Mol Dis       Date:  2014-07-04       Impact factor: 3.039

9.  Clinical assay of four thiol amino acid redox couples by LC-MS/MS: utility in thalassemia.

Authors:  Jung H Suh; Robert Kim; Burcu Yavuz; Daniel Lee; Ashutosh Lal; Bruce N Ames; Mark K Shigenaga
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-02       Impact factor: 3.205

10.  Impact of MRI technique on clinical decision-making in patients with liver iron overload: comparison of FerriScan- versus R2*-derived liver iron concentration.

Authors:  Marshall S Sussman; Richard Ward; Kevin H M Kuo; George Tomlinson; Kartik S Jhaveri
Journal:  Eur Radiol       Date:  2020-01-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.